How Glytec’s product strategy aligns with value-based reforms by addressing diabetes therapy across all settings and transitions of care. AJMC interviews Dr. Andrew Rhinehart, Chief Medical Officer.
April 1, 2016
How Glytec’s product strategy aligns with value-based reforms by addressing diabetes therapy across all settings and transitions of care. AJMC interviews Dr. Andrew Rhinehart, Chief Medical Officer.
